Review by Consultants

Depending on the submission, the Division of OTC Drug Products may request that the submission be reviewed by consultants, such as chemists or statisticians, from other review divisions or by experts (federal government employees) outside of CDER's offices.  When the consultants complete their reviews, their comments are returned to the Division of OTC Drug Products.